je.st
news
Seattle Genetics Initiates Two Phase I Trials Of SGN-CD19A
2013-02-06 10:00:00| drugdiscoveryonline News Articles
Seattle Genetics, Inc. recently announced the initiation of two phase I clinical trials of SGN-CD19A, one for patients with B-cell acute lymphoblastic leukemia (ALL) and one for patients with B-cell non-Hodgkin lymphomas
Tags: phase
seattle
trials
genetics
Category:Biotechnology and Pharmaceuticals